MeCP2 isoform e1 mutant mice recapitulate motor and metabolic phenotypes of Rett syndrome
Open Access
- 21 August 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 27 (23) , 4077-4093
Abstract
Mutations in the X-linked gene MECP2 cause the majority of Rett syndrome (RTT) cases. Two differentially spliced isoforms of exons 1 and 2 (MeCP2-e1 and MeCP2-e2) contribute to the diverse functions of MeCP2, but only mutations in exon 1, not exon 2, are observed in RTT. We previously described an isoform-specific MeCP2-e1-deficient male mouse model of a human RTT mutation that lacks MeCP2-e1 while preserving expression of MeCP2-e2. However, RTT patients are heterozygous females that exhibit delayed and progressive symptom onset beginning in late infancy, including neurologic as well as metabolic, immune, respiratory and gastrointestinal phenotypes. Consequently, we conducted a longitudinal assessment of symptom development in MeCP2-e1 mutant females and males. A delayed and progressive onset of motor impairments was observed in both female and male MeCP2-e1 mutant mice, including hind limb clasping and motor deficits in gait and balance. Because these motor impairments were significantly impacted by age-dependent increases in body weight, we also investigated metabolic phenotypes at an early stage of disease progression. Both male and female MeCP2-e1 mutants exhibited significantly increased body fat compared to sex-matched wild-type littermates prior to weight differences. Mecp2e1-/y males exhibited significant metabolic phenotypes of hypoactivity, decreased energy expenditure, increased respiratory exchange ratio, but decreased food intake compared to wild-type. Untargeted analysis of lipid metabolites demonstrated a distinguishable profile in MeCP2-e1 female mutant liver characterized by increased triglycerides. Together, these results demonstrate that MeCP2-e1 mutation in mice of both sexes recapitulates early and progressive metabolic and motor phenotypes of human RTT.Keywords
All Related Versions
Funding Information
- National Institutes of Health (T32MH073124-06, 3RO1NS081913-11S1, 5R01NS081913-14, U54HD079125, UL1TR000002, 1R01NS085709)
- National Alliance for Research on Schizophrenia and Depression
- International Rett Syndrome Foundation (UL1 TR001860)
- University of California
- National Institute of Diabetes and Digestive Kidney Disease (DK076169, DK115255)
This publication has 88 references indexed in Scilit:
- The neuron-specific chromatin regulatory subunit BAF53b is necessary for synaptic plasticity and memoryNature Neuroscience, 2013
- Methyl CpG-binding Protein Isoform MeCP2_e2 Is Dispensable for Rett Syndrome Phenotypes but Essential for Embryo Viability and Placenta DevelopmentJournal of Biological Chemistry, 2012
- Rett syndrome mutation MeCP2 T158A disrupts DNA binding, protein stability and ERP responsesNature Neuroscience, 2011
- Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse modelJournal of Molecular Medicine, 2010
- Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndromeBone, 2009
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant miceProceedings of the National Academy of Sciences, 2009
- Deletion of Mecp2 in Sim1-Expressing Neurons Reveals a Critical Role for MeCP2 in Feeding Behavior, Aggression, and the Response to StressNeuron, 2008
- RETRACTED ARTICLE: Neurotrophic effects of Cerebrolysin in the Mecp2308/Y transgenic model of Rett syndromeActa Neuropathologica, 2008
- Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndromeHuman Molecular Genetics, 2004
- Automated apparatus for quantitation of social approach behaviors in miceGenes, Brain and Behavior, 2004